US7517884B2
(en)
|
1998-03-30 |
2009-04-14 |
Kalypsys Inc. |
Sulfonyl-substituted bicyclic compounds as modulators of PPAR
|
TWI263497B
(en)
|
2002-03-29 |
2006-10-11 |
Lilly Co Eli |
Pyridinoylpiperidines as 5-HT1F agonists
|
TW200526626A
(en)
|
2003-09-13 |
2005-08-16 |
Astrazeneca Ab |
Chemical compounds
|
GB0325956D0
(en)
*
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US7745630B2
(en)
*
|
2003-12-22 |
2010-06-29 |
Justin Stephen Bryans |
Triazolyl piperidine arginine vasopressin receptor modulators
|
WO2005061489A1
(en)
*
|
2003-12-24 |
2005-07-07 |
Prosidion Limited |
Heterocyclic derivatives as gpcr receptor agonists
|
AU2005214378A1
(en)
*
|
2004-02-18 |
2005-09-01 |
Astrazeneca Ab |
Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
|
US7269708B2
(en)
*
|
2004-04-20 |
2007-09-11 |
Rambus Inc. |
Memory controller for non-homogenous memory system
|
NZ551603A
(en)
|
2004-06-24 |
2010-11-26 |
Incyte Corp |
N-substituted piperidines and their use as pharmaceuticals
|
MX2007001540A
(es)
*
|
2004-08-10 |
2007-04-23 |
Incyte Corp |
Compuestos amido y sus usos como farmaceuticos.
|
WO2006034440A2
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
JP5094398B2
(ja)
|
2004-09-20 |
2012-12-12 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
複素環式誘導体およびステアロイル−CoAデサチュラーゼのメディエータとしてのそれらの使用
|
TW200626138A
(en)
|
2004-09-20 |
2006-08-01 |
Xenon Pharmaceuticals Inc |
Heterocyclic derivatives and their use as therapeutic agents
|
WO2006034341A2
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
CA2580857A1
(en)
|
2004-09-20 |
2006-09-28 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
WO2006034441A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
TW200630337A
(en)
|
2004-10-14 |
2006-09-01 |
Euro Celtique Sa |
Piperidinyl compounds and the use thereof
|
WO2006055187A1
(en)
|
2004-10-29 |
2006-05-26 |
Kalypsys, Inc. |
Sulfonyl-substituted bicyclic compounds as modulators of ppar
|
KR101063585B1
(ko)
|
2005-02-17 |
2011-09-07 |
아스텔라스세이야쿠 가부시키가이샤 |
피리딜 비방향족 질소 함유 헤테로환-1-카르복실산에스테르 유도체
|
US8399489B2
(en)
|
2005-02-18 |
2013-03-19 |
Astrazeneca Ab |
Antibacterial piperdine derivatives
|
GB0508319D0
(en)
|
2005-04-25 |
2005-06-01 |
Novartis Ag |
Organic compounds
|
GB0510140D0
(en)
*
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B2
|
GB0510142D0
(en)
*
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds A1
|
GB0510139D0
(en)
*
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
GB0510141D0
(en)
*
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
KR20080027463A
(ko)
*
|
2005-05-18 |
2008-03-27 |
아덱스 파마 에스에이 |
대사성 글루타메이트 수용체의 양성 알로스테릭조절자로서의 치환된 옥사디아졸 유도체
|
AU2006343359A1
(en)
|
2005-06-03 |
2007-11-15 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
|
JP2008545008A
(ja)
*
|
2005-06-30 |
2008-12-11 |
プロシディオン・リミテッド |
Gpcrアゴニスト
|
WO2007003960A1
(en)
*
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
Gpcr agonists
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
BRPI0613859B8
(pt)
|
2005-07-26 |
2021-05-25 |
Bial Portela & Ca Sa |
inibidores da comt, seus usos, e composição farmacêutica
|
TW200800946A
(en)
*
|
2005-08-15 |
2008-01-01 |
Astrazeneca Ab |
Substituted piperazines as metabotropic glutamate receptor antagonists
|
HUP0500920A2
(en)
*
|
2005-10-05 |
2007-07-30 |
Richter Gedeon Nyrt |
Oxadiazole derivatives, process for their preparation and their use
|
JP5322650B2
(ja)
|
2005-10-25 |
2013-10-23 |
カリプシス・インコーポレーテッド |
Ppar調節剤の塩および代謝障害の治療方法
|
KR101331768B1
(ko)
|
2005-11-08 |
2013-11-22 |
버텍스 파마슈티칼스 인코포레이티드 |
Atp 결합 카세트 수송체의 헤테로사이클릭 조정제
|
US7671221B2
(en)
|
2005-12-28 |
2010-03-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
DE102005062990A1
(de)
|
2005-12-28 |
2007-07-05 |
Grünenthal GmbH |
Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln
|
DE102005062991A1
(de)
*
|
2005-12-28 |
2007-07-05 |
Grünenthal GmbH |
Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln
|
PA8713501A1
(es)
|
2006-02-07 |
2009-09-17 |
Wyeth Corp |
INHIBIDORES DE 11-BETA HIDROXIESTEROIDE DEHIDROGENASA - 11ßHSD1
|
US7951824B2
(en)
*
|
2006-02-17 |
2011-05-31 |
Hoffman-La Roche Inc. |
4-aryl-pyridine-2-carboxyamide derivatives
|
PL2001849T3
(pl)
|
2006-03-29 |
2015-04-30 |
Hoffmann La Roche |
Pochodne pirydyny i pirymidyny jako antagoniści mGluR2
|
US8247442B2
(en)
|
2006-03-29 |
2012-08-21 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and their use
|
EP1845097A1
(en)
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazole derivatives as COMT inhibitors
|
WO2007118854A1
(en)
|
2006-04-13 |
2007-10-25 |
Euro-Celtique S.A. |
Benzenesulfonamide compounds and the use thereof
|
TW200815353A
(en)
|
2006-04-13 |
2008-04-01 |
Euro Celtique Sa |
Benzenesulfonamide compounds and their use
|
TW200811156A
(en)
*
|
2006-05-05 |
2008-03-01 |
Astrazeneca Ab |
mGluR5 modulators IV
|
TW200811157A
(en)
|
2006-05-05 |
2008-03-01 |
Astrazeneca Ab |
mGluR5 modulators I
|
US7943622B2
(en)
|
2006-06-06 |
2011-05-17 |
Cornerstone Therapeutics, Inc. |
Piperazines, pharmaceutical compositions and methods of use thereof
|
FR2903405B1
(fr)
*
|
2006-07-04 |
2011-09-09 |
Pasteur Institut |
Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications
|
MX2009002019A
(es)
|
2006-08-24 |
2009-03-09 |
Novartis Ag |
Derivados de 2-(pirazin-2-il)-tiazol y 2-(1h-pirazol-3-il)-tiazol asi como compuestos relacionados como inhibidores de la estearoil-coa-desaturasa (scd) para el tratamiento de trastornos metabolicos, cardiovasculares, y otros.
|
BRPI0718509A2
(pt)
|
2006-09-22 |
2015-09-29 |
Novartis Ag |
compostos orgânicos heterocíclicos
|
CA2663984C
(en)
|
2006-10-18 |
2012-02-21 |
Pfizer Products Inc. |
Biaryl ether urea compounds
|
GB0622202D0
(en)
*
|
2006-11-07 |
2006-12-20 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US7754739B2
(en)
|
2007-05-09 |
2010-07-13 |
Vertex Pharmaceuticals Incorporated |
Modulators of CFTR
|
AU2007336238A1
(en)
|
2006-12-20 |
2008-06-26 |
Novartis Ag |
2-substituted 5-membered heterocycles as SCD inhibitors
|
US20080176861A1
(en)
|
2007-01-23 |
2008-07-24 |
Kalypsys, Inc. |
Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
|
EP2124947B1
(en)
|
2007-01-31 |
2017-07-19 |
BIAL - Portela & Ca., S.A. |
Dosage regimen for comt inhibitors
|
US8399486B2
(en)
|
2007-04-09 |
2013-03-19 |
Purdue Pharma L.P. |
Benzenesulfonyl compounds and the use thereof
|
WO2008141119A2
(en)
|
2007-05-09 |
2008-11-20 |
Vertex Pharmaceuticals Incorporated |
Modulators of cftr
|
US8853392B2
(en)
|
2007-06-03 |
2014-10-07 |
Vanderbilt University |
Benzamide mGluR5 positive allosteric modulators and methods of making and using same
|
EA200971143A1
(ru)
*
|
2007-06-03 |
2010-06-30 |
Вандербилт Юниверсити |
Бензамидные mglur5 позитивные аллостерические модуляторы и способы их получения и применения
|
WO2009038974A1
(en)
|
2007-09-20 |
2009-03-26 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
RU2488591C2
(ru)
|
2007-09-26 |
2013-07-27 |
Маунт Синай Скул Оф Медсин |
Аналоги азацитидина и их применение
|
US8765736B2
(en)
|
2007-09-28 |
2014-07-01 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and the use thereof
|
KR20100064381A
(ko)
*
|
2007-10-10 |
2010-06-14 |
다케다 야쿠힌 고교 가부시키가이샤 |
아미드 화합물
|
PE20090982A1
(es)
|
2007-11-05 |
2009-08-13 |
Novartis Ag |
Derivados de piperidina como inhibidores de la proteina de transferencia de colesteril-ester (cetp)
|
EP2229356B1
(en)
|
2007-12-03 |
2011-10-12 |
Novartis AG |
1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
|
SG186638A1
(en)
|
2007-12-07 |
2013-01-30 |
Vertex Pharma |
Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
|
KR20150066608A
(ko)
|
2007-12-07 |
2015-06-16 |
버텍스 파마슈티칼스 인코포레이티드 |
사이클로알킬카복시아미도-피리딘 벤조산의 제조 방법
|
WO2009084034A2
(en)
*
|
2007-12-18 |
2009-07-09 |
Glenmark Pharmaceuticals, S. A. |
Chromane derivatives as trpv3 modulators
|
MX2010009043A
(es)
*
|
2008-02-28 |
2010-10-25 |
Bial Portela & Ca Sa |
Composicion farmaceutica para farmacos poco solubles.
|
CA2716109C
(en)
|
2008-02-28 |
2016-07-19 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl derivatives as cftr modulators
|
CA2718772C
(en)
|
2008-03-17 |
2017-05-02 |
David Alexander Learmonth |
Crystal forms of 5-[3-(2,5-dichloro-4,6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
WO2010004379A2
(en)
*
|
2008-06-17 |
2010-01-14 |
Glenmark Pharmaceuticals S.A. |
Chromane derivatives as trpv3 modulators
|
TWI434842B
(zh)
|
2008-07-14 |
2014-04-21 |
Astellas Pharma Inc |
Azole compounds
|
GB0813144D0
(en)
|
2008-07-17 |
2008-08-27 |
Glaxo Group Ltd |
Novel compounds
|
GB0813142D0
(en)
|
2008-07-17 |
2008-08-27 |
Glaxo Group Ltd |
Novel compounds
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
US8609696B2
(en)
|
2008-12-18 |
2013-12-17 |
Boehringer Ingelheim International Gmbh |
Serotonin 5-HT2B receptor inhibitors
|
EP3078658B1
(en)
*
|
2008-12-22 |
2019-04-10 |
ChemoCentryx, Inc. |
C5ar antagonists
|
WO2010096371A2
(en)
*
|
2009-02-18 |
2010-08-26 |
Boehringer Ingelheim International Gmbh |
Heterocyclic compounds which modulate the cb2 receptor
|
US20100222381A1
(en)
|
2009-02-27 |
2010-09-02 |
Hariprasad Vankayalapati |
Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
|
CN102438595B
(zh)
*
|
2009-04-01 |
2016-04-27 |
巴尔-波特拉及康邦亚股份有限公司 |
包括硝基儿茶酚衍生物的药物制剂及其制备方法
|
CN105878242A
(zh)
|
2009-04-01 |
2016-08-24 |
巴尔-波特拉及康邦亚股份有限公司 |
包括硝基儿茶酚衍生物的药物制剂及其制备方法
|
AU2010232497B2
(en)
*
|
2009-04-02 |
2016-05-19 |
Colucid Pharmaceuticals, Inc. |
Composition of 2,4,6-trifluoro-N-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
|
AU2010239253A1
(en)
*
|
2009-04-23 |
2011-11-24 |
Merck Sharp & Dohme Corp. |
2-alkyl piperidine mGluR5 receptor modulators
|
US8673920B2
(en)
|
2009-05-06 |
2014-03-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
SG176628A1
(en)
|
2009-06-05 |
2012-01-30 |
Link Medicine Corp |
Aminopyrrolidinone derivatives and uses thereof
|
TW201044234A
(en)
*
|
2009-06-08 |
2010-12-16 |
Chunghwa Picture Tubes Ltd |
Method of scanning touch panel
|
WO2011035143A2
(en)
*
|
2009-09-17 |
2011-03-24 |
The Regents Of The University Of Michigan |
Methods and compositions for inhibiting rho-mediated diseases and conditions
|
US8389536B2
(en)
|
2009-10-27 |
2013-03-05 |
Hoffmann-La Roche Inc. |
Positive allosteric modulators (PAM)
|
US8394858B2
(en)
|
2009-12-03 |
2013-03-12 |
Novartis Ag |
Cyclohexane derivatives and uses thereof
|
US8586581B2
(en)
|
2009-12-17 |
2013-11-19 |
Hoffmann-La Roche Inc |
Ethynyl compounds useful for treatment of CNS disorders
|
WO2011075699A2
(en)
|
2009-12-18 |
2011-06-23 |
Sunovion Pharmaceuticals Inc. |
Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
|
EP2523936A1
(en)
|
2010-01-15 |
2012-11-21 |
Boehringer Ingelheim International GmbH |
Compounds which modulate the cb2 receptor
|
CA2795062A1
(en)
|
2010-04-02 |
2011-10-06 |
Colucid Pharmaceuticals, Inc. |
Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists
|
RU2592368C2
(ru)
|
2010-04-07 |
2016-07-20 |
Вертекс Фармасьютикалз Инкорпорейтед |
ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, ВКЛЮЧАЮЩИЕ 3-(2, 2-ДИФТОРБЕНЗО[d][1, 3]ДИОКСОЛ-5-ИЛ)ЦИКЛОПРОПАНКАРБОКСАМИДО)-3-МЕТИЛПИРИДИН-2-ИЛ)БЕНЗОЙНУЮ КИСЛОТУ, И ИХ ВВЕДЕНИЕ
|
US8420661B2
(en)
|
2010-04-13 |
2013-04-16 |
Hoffmann-La Roche Inc. |
Arylethynyl derivatives
|
EP2566853B1
(en)
|
2010-05-05 |
2017-01-25 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
NZ604035A
(en)
|
2010-06-04 |
2015-02-27 |
Albany Molecular Res Inc |
Glycine transporter-1 inhibitors, methods of making them, and uses thereof
|
PL2585064T3
(pl)
|
2010-06-24 |
2017-09-29 |
Chemocentryx, Inc. |
Antagoniści C5AR
|
JP5746764B2
(ja)
|
2010-07-22 |
2015-07-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cb2受容体を調節する化合物
|
EP2632469A2
(en)
*
|
2010-10-25 |
2013-09-04 |
Merck Sharp & Dohme Corp. |
Tricyclic mglur5 receptor modulators
|
WO2012058116A1
(en)
|
2010-10-27 |
2012-05-03 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
EP2632464B1
(en)
|
2010-10-29 |
2015-04-29 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
US8772300B2
(en)
|
2011-04-19 |
2014-07-08 |
Hoffmann-La Roche Inc. |
Phenyl or pyridinyl-ethynyl derivatives
|
MY165141A
(en)
|
2011-04-26 |
2018-02-28 |
Hoffmann La Roche |
Pyrazolidin-3-one derivatives
|
DK2702051T3
(en)
|
2011-04-26 |
2015-03-16 |
Hoffmann La Roche |
Ethynyl derivatives AS POSITIVE allosteric modulators mGluR5
|
CN104066729A
(zh)
|
2011-08-15 |
2014-09-24 |
英特穆恩公司 |
溶血磷脂酸受体拮抗剂
|
RU2014110401A
(ru)
|
2011-08-19 |
2015-09-27 |
Мерк Шарп И Доум Корп. |
Ингибиторы внешнего медуллярного калиевого канала почек
|
UY34305A
(es)
|
2011-09-01 |
2013-04-30 |
Novartis Ag |
Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
|
WO2013039802A1
(en)
|
2011-09-16 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
US20130123254A1
(en)
|
2011-09-30 |
2013-05-16 |
Barbara Biemans |
Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification
|
US9926309B2
(en)
|
2011-10-05 |
2018-03-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with anti-infective activity
|
EP2763532B1
(en)
|
2011-10-05 |
2018-09-19 |
The Board of Trustees of the Leland Stanford Junior University |
Pi-kinase inhibitors with broad spectrum anti-infective activity
|
UA110862C2
(uk)
|
2011-10-07 |
2016-02-25 |
Ф. Хоффманн-Ля Рош Аг |
Похідні етинілу як алостеричні модулятори метаботропного рецептора глутамату mglur 5
|
UA110995C2
(uk)
|
2011-10-07 |
2016-03-10 |
Ф. Хоффманн-Ля Рош Аг |
Етинільні похідні як модулятори метаботропного глутаматного рецептора
|
WO2013062857A1
(en)
*
|
2011-10-25 |
2013-05-02 |
Merck Sharp & Dohme Corp. |
Piperidinyl alkyne orexin receptor antagonists
|
US8999990B2
(en)
|
2011-10-25 |
2015-04-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
US8999991B2
(en)
|
2011-10-25 |
2015-04-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
EP2773351B1
(en)
|
2011-10-31 |
2017-08-23 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
WO2013066717A1
(en)
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
US9139585B2
(en)
|
2011-10-31 |
2015-09-22 |
Merck Sharp & Dohme Corp. |
Inhibitors of the Renal Outer Medullary Potassium channel
|
PT3604299T
(pt)
|
2011-12-13 |
2023-10-31 |
Bial Portela & Ca Sa |
Composto químico útil como intermediário para a preparação de um inibidor de catecol-o-metiltransferase
|
US9206199B2
(en)
|
2011-12-16 |
2015-12-08 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
KR101939710B1
(ko)
|
2011-12-21 |
2019-01-17 |
노비라 테라퓨틱스, 인코포레이티드 |
B형 간염의 항바이러스성 제제
|
UA113638C2
(xx)
|
2012-02-02 |
2017-02-27 |
|
4-(бензоімідазол-2-іл)-тіазольні сполуки та споріднені азапохідні
|
EA029899B1
(ru)
|
2012-06-04 |
2018-05-31 |
Идорсиа Фармасьютиклз Лтд |
Производные бензимидазол-пролина
|
PE20150184A1
(es)
|
2012-07-17 |
2015-02-13 |
Hoffmann La Roche |
Derivados de ariletinilo
|
AR092031A1
(es)
|
2012-07-26 |
2015-03-18 |
Merck Sharp & Dohme |
Inhibidores del canal de potasio medular externo renal
|
UA113223C2
(xx)
|
2012-08-13 |
2016-12-26 |
|
Арилетинілпіримідини
|
KR20210081451A
(ko)
|
2012-08-28 |
2021-07-01 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
설파모일-아릴아미드 및 b형 간염 치료제로서의 그 용도
|
PL2900659T3
(pl)
|
2012-09-27 |
2017-02-28 |
F.Hoffmann-La Roche Ag |
Pochodne aryloetynylowe
|
WO2014057435A1
(en)
|
2012-10-10 |
2014-04-17 |
Actelion Pharmaceuticals Ltd |
Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone derivatives
|
EP2925322B1
(en)
|
2012-11-29 |
2018-10-24 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
AP2015008591A0
(en)
|
2012-12-11 |
2013-07-31 |
Takeda Pharmaceutical |
Heterocyclic compounds
|
EP2934533B1
(en)
|
2012-12-19 |
2017-11-15 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
EP2956142B1
(en)
|
2013-02-18 |
2017-09-20 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
WO2014131847A1
(en)
|
2013-02-28 |
2014-09-04 |
Janssen R&D Ireland |
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
WO2014165128A2
(en)
|
2013-03-12 |
2014-10-09 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
CA2902135A1
(en)
|
2013-03-12 |
2014-09-18 |
Actelion Pharmaceuticals Ltd |
Azetidine amide derivatives as orexin receptor antagonists
|
WO2014150132A1
(en)
|
2013-03-15 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
PT2981536T
(pt)
|
2013-04-03 |
2017-08-09 |
Janssen Sciences Ireland Uc |
Derivados de n-fenil-carboxamida e sua utilização como medicamentos para o tratamento da hepatite b
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
EP2803668A1
(en)
|
2013-05-17 |
2014-11-19 |
Boehringer Ingelheim International Gmbh |
Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
|
CA2916338C
(en)
|
2013-07-22 |
2021-07-06 |
Actelion Pharmaceuticals Ltd |
1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives
|
WO2015011281A1
(en)
|
2013-07-25 |
2015-01-29 |
Janssen R&D Ireland |
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
WO2015017305A1
(en)
|
2013-07-31 |
2015-02-05 |
Merck Sharp & Dohme Corp |
Inhibitors of the renal outer medullary potassium channel
|
WO2015018027A1
(en)
|
2013-08-08 |
2015-02-12 |
Merck Sharp & Dohme Corp. |
Thiazole orexin receptor antagonists
|
BR112016008378B1
(pt)
|
2013-10-14 |
2022-11-08 |
Eisai R&D Management Co., Ltd |
Compostos de quinolina seletivamente substituídos ou sal dos mesmos, e composição farmacêutica contendo os ditos compostos
|
MY192489A
(en)
|
2013-10-14 |
2022-08-23 |
Eisai R&D Man Co Ltd |
Selectively substituted quinoline compounds
|
DK3060547T3
(en)
|
2013-10-23 |
2018-01-15 |
Janssen Sciences Ireland Uc |
CARBOXAMIDE DERIVATIVES AND USE THEREOF AS MEDICINES FOR TREATMENT OF HEPATITS B
|
AU2014349010C1
(en)
|
2013-11-12 |
2020-08-06 |
Vertex Pharmaceuticals Incorporated |
Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases
|
DK3077391T3
(en)
|
2013-12-04 |
2018-10-22 |
Idorsia Pharmaceuticals Ltd |
USE OF BENZIMIDAZOLE PROLINE DERIVATIVES
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US10392349B2
(en)
|
2014-01-16 |
2019-08-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
CA2936947A1
(en)
|
2014-02-05 |
2015-08-13 |
Novira Therapeutics, Inc. |
Combination therapy for treatment of hbv infections
|
US11078193B2
(en)
|
2014-02-06 |
2021-08-03 |
Janssen Sciences Ireland Uc |
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
AR099789A1
(es)
|
2014-03-24 |
2016-08-17 |
Actelion Pharmaceuticals Ltd |
Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
WO2015187541A1
(en)
|
2014-06-02 |
2015-12-10 |
Children's Medical Center Corporation |
Methods and compositions for immunomodulation
|
DK3200791T3
(da)
|
2014-09-29 |
2020-05-25 |
Chemocentryx Inc |
Fremgangsmåder og mellemprodukter i fremstilling af C5AR- antagonister
|
WO2016065585A1
(en)
*
|
2014-10-30 |
2016-05-06 |
Merck Sharp & Dohme Corp. |
Piperidine isoxazole and isothiazole orexin receptor antagonists
|
WO2016065586A1
(en)
*
|
2014-10-30 |
2016-05-06 |
Merck Sharp & Dohme Corp. |
Pyrazole, triazole and tetrazole orexin receptor antagonists
|
WO2016065584A1
(en)
*
|
2014-10-30 |
2016-05-06 |
Merck Sharp & Dohme Corp. |
Piperidine oxadiazole and thiadiazole orexin receptor antagonists
|
JP6494757B2
(ja)
|
2014-11-18 |
2019-04-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
ハイスループット試験高速液体クロマトグラフィーを行うプロセス
|
WO2016083863A1
(en)
|
2014-11-28 |
2016-06-02 |
Bial - Portela & Ca, S.A. |
Medicaments for slowing parkinson's disease
|
AR103399A1
(es)
|
2015-01-15 |
2017-05-10 |
Actelion Pharmaceuticals Ltd |
Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
|
TR201900680T4
(tr)
|
2015-01-15 |
2019-02-21 |
Idorsia Pharmaceuticals Ltd |
CXCR3 Reseptör modülatörleri olarak hidroksialkil- piperazin türevleri.
|
WO2016127358A1
(en)
|
2015-02-12 |
2016-08-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of renal outer medullary potassium channel
|
JP2018510159A
(ja)
|
2015-03-19 |
2018-04-12 |
ノヴィラ・セラピューティクス・インコーポレイテッド |
アゾカン及びアゾナン誘導体及びb型肝炎感染症の治療法
|
PL3286176T3
(pl)
*
|
2015-04-24 |
2020-11-30 |
Pfizer Inc. |
Krystaliczne formy maleinianu 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-ilo)-1-metylopiperydyn-4-ylo)-3-(4-cyjanofenylo)mocznika
|
CR20170536A
(es)
|
2015-06-03 |
2018-02-01 |
Hoffmann La Roche |
Derivados de etinilo
|
US10875876B2
(en)
|
2015-07-02 |
2020-12-29 |
Janssen Sciences Ireland Uc |
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
CN106349228B
(zh)
|
2015-07-17 |
2019-07-09 |
广东东阳光药业有限公司 |
取代的喹唑啉酮类化合物及其制备方法和用途
|
JP6845231B2
(ja)
|
2015-09-29 |
2021-03-17 |
ノヴィラ・セラピューティクス・インコーポレイテッド |
B型肝炎抗ウイルス薬の結晶形態
|
EP3402486A4
(en)
|
2016-01-14 |
2019-08-28 |
ChemoCentryx, Inc. |
PROCESS FOR TREATING C3 GLOMERULOPATHY
|
US11091472B2
(en)
|
2016-02-26 |
2021-08-17 |
The Regents Of The University Of California |
PI-kinase inhibitors with anti-infective activity
|
JP2019511542A
(ja)
|
2016-04-15 |
2019-04-25 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
カプシド集合阻害剤を含む組み合わせ及び方法
|
EA201990001A1
(ru)
|
2016-06-07 |
2019-05-31 |
Джакобио Фармасьютикалс Ко., Лтд. |
Новые гетероциклические производные, применимые в качестве ингибиторов shp2
|
EP3375778A1
(en)
|
2017-03-14 |
2018-09-19 |
Artax Biopharma Inc. |
Aryl-piperidine derivatives
|
US10988466B2
(en)
|
2017-03-23 |
2021-04-27 |
Jacobio Pharmaceuticals Co., Ltd. |
Heterocyclic derivatives useful as SHP2 inhibitors
|
US11440922B2
(en)
*
|
2017-06-29 |
2022-09-13 |
Recordati Industria Chimica e Farmacentica S.p.A. |
Heterocyclylmethylidene derivatives and their use as modulators of mGluR5 receptors
|
SG11202000143PA
(en)
|
2017-07-10 |
2020-02-27 |
Celgene Corp |
Antiproliferative compounds and methods of use thereof
|
SG11202001684PA
(en)
|
2017-10-06 |
2020-03-30 |
Forma Therapeutics Inc |
Inhibiting ubiquitin specific peptidase 30
|
CR20200347A
(es)
|
2018-02-13 |
2020-09-23 |
Gilead Sciences Inc |
Inhibidores pd-1/pd-l1
|
AU2019235522A1
(en)
|
2018-03-14 |
2020-09-03 |
Janssen Sciences Ireland Unlimited Company |
Capsid assembly modulator dosing regimen
|
CN112041311B
(zh)
|
2018-04-19 |
2023-10-03 |
吉利德科学公司 |
Pd-1/pd-l1抑制剂
|
KR20230159715A
(ko)
|
2018-07-13 |
2023-11-21 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
WO2020072964A1
(en)
|
2018-10-05 |
2020-04-09 |
Forma Therapeutics, Inc. |
Fused pyrrolines which act as ubiquitin-specific protease 30 (usp30) inhibitors
|
TWI767148B
(zh)
|
2018-10-10 |
2022-06-11 |
美商弗瑪治療公司 |
抑制脂肪酸合成酶(fasn)
|
AU2019366355B2
(en)
|
2018-10-24 |
2022-10-13 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
US11034669B2
(en)
|
2018-11-30 |
2021-06-15 |
Nuvation Bio Inc. |
Pyrrole and pyrazole compounds and methods of use thereof
|
EP3914592A1
(en)
*
|
2019-01-25 |
2021-12-01 |
University of Virginia Patent Foundation |
Inhibitors of spinster homolog 2 (spns2) for use in therapy
|
US11096931B2
(en)
|
2019-02-22 |
2021-08-24 |
Janssen Sciences Ireland Unlimited Company |
Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
|
AU2020269897A1
(en)
|
2019-05-06 |
2021-10-14 |
Janssen Sciences Ireland Unlimited Company |
Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases
|
TWI829107B
(zh)
|
2019-07-09 |
2024-01-11 |
美商美國禮來大藥廠 |
大規模製備2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺半琥珀酸鹽的方法及中間體,以及2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺醋酸鹽之製備
|
AU2020397059A1
(en)
|
2019-12-06 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofurans as modulators of sodium channels
|
JP2023509452A
(ja)
|
2020-01-03 |
2023-03-08 |
バーグ エルエルシー |
がんを処置するためのube2kモジュレータとしての多環式アミド
|
EP4210824A1
(en)
*
|
2020-09-09 |
2023-07-19 |
University of Virginia Patent Foundation |
Inhibitors of spinster homolog 2 (spns2) for use in therapy
|
WO2022069953A1
(en)
*
|
2020-09-29 |
2022-04-07 |
Ranjith Siddaraj |
Synthesis and characterization of (s)-3-(5- fluoropyridin-2-yl)-5-(piperidin-3-yl)-l,2,4-oxadiazole derivatives and their secretory phospholipase a2 (spla2) inhibitor activity
|
IL308953A
(en)
|
2021-06-04 |
2024-01-01 |
Vertex Pharma |
N-Hydroalkyl(Hetero)Aryl)Tetrahydrofuran Carboxamides as Natrene Channel Modulators
|
CA3223081A1
(en)
|
2021-07-15 |
2023-01-19 |
Samir Mitragotri |
Compositions and methods relating to cells with adhered particles
|